| Phase I Trial of Selinexor (KPT-330) and Ifosfamide, Carboplatin, Etoposide (ICE) in Peripheral T-cell Lymphoma (NCT03212937) | National Cancer Centre, Singapore | 2016-07-01 |
| A Study to Test the Combination of Selinexor (KPT-330), Ixazomib, and Dexamethasone in Patients With Myeloma (NCT02831686) | Memorial Sloan Kettering Cancer Center | 2016-07-01 |
| Nivolumab and Yttrium Y 90 Glass Microspheres in Treating Patients With Advanced Liver Cancer (NCT02837029) | Northwestern University | 2016-07-01 |
| Non-randomized, Open-labeled, Interventional, Single Group, Proof of Concept Study With Multi-modality Approach in Cases of Brain Death Due to Traumatic Brain Injury Having Diffuse Axonal Injury (NCT02742857) | Bioquark Inc. | 2016-07-01 |
| A Phase 1/2 Trial SRA737 in Combination With Gemcitabine and Cisplatin or Gemcitabine Alone in Advanced Cancer Subjects (NCT02797977) | Sierra Oncology LLC - a GSK company | 2016-07-01 |
| Sildenafil Administration to Treat Neonatal Encephalopathy (NCT02812433) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2016-07-01 |
| Pharmacokinetic Evaluation of Intranasal, Intramuscular, and Oral Naltrexone in Healthy Volunteers (NCT02750748) | National Institute on Drug Abuse (NIDA) | 2016-07-01 |
| Clinical Trial With Subcutaneous Immunotherapy in Depot Presentation in Patients With Allergic Rhinoconjunctivitis Sensitized to House Dust Mites (NCT02881879) | Roxall Medicina España S.A | 2016-07-01 |
| A Study to Evaluate the Effects of Esketamine on Cardiac Repolarization in Healthy Participants (NCT02737605) | Janssen Research & Development, LLC | 2016-07-01 |
| Pharmacokinetic Study Comparing Salmeterol/Fluticasone Easyhaler and Seretide Diskus (NCT03060044) | Orion Corporation, Orion Pharma | 2016-07-01 |
| Study to Assess Safety, Tolerability, and Efficacy of GMI-1271 in Patients With Calf-level Deep Venous Thrombosis (DVT) (NCT02744833) | GlycoMimetics Incorporated | 2016-07-01 |
| A Study of Combinations of D-CIK Immunotherapy And Anti-PD-1 In Refractory Solid Tumors (NCT02886897) | Sun Yat-sen University | 2016-07-01 |
| Exenatide Once Weekly for Smoking Cessation (NCT02975297) | The University of Texas Health Science Center, Houston | 2016-07-01 |
| Combination of Cryosurgery and NK Immunotherapy for Advanced Esophageal Cancer (NCT02843581) | Fuda Cancer Hospital, Guangzhou | 2016-07-01 |
| Effectiveness of a Medication Wallet Card (NCT02820129) | McMaster University | 2016-07-01 |
| A Mass Balance Study to Investigate the Absorption, Metabolism, and Excretion Of [14C] Fruquintinib (NCT02689752) | Hutchison Medipharma Limited | 2016-07-01 |
| Catabolic Marker Levels After Platelet Poor Plasma (PPP) Lavage (NCT03120988) | Regenexx, LLC | 2016-07-01 |
| A Study of LY3023414 Formulations and the Effect of Food (NCT02818335) | Eli Lilly and Company | 2016-07-01 |
| Study to Evaluate the Effect of Cytochrome P450 (CYP) 3A Inhibition and Induction on the Pharmacokinetics of CC-220 in Healthy Subjects (NCT02820935) | Celgene Corporation | 2016-07-01 |
| A Study to Evaluate the Safety of Neural Stem Cells in Patients With Parkinson's Disease (NCT02452723) | Cyto Therapeutics Pty Limited | 2016-07-01 |
| Combination of Cryosurgey and NK Immunotherapy for Recurrent Ovarian Cancer (NCT02849353) | Fuda Cancer Hospital, Guangzhou | 2016-07-01 |
| Single Ascending Dose Study to Evaluate Pharmacokinetics and Food-Effect in Healthy Volunteers (NCT02853643) | Asana BioSciences | 2016-07-01 |
| Phase I/II Study of EP-guided Noninvasive Cardiac Radioablation for Treatment of Ventricular Tachycardia (NCT02919618) | Washington University School of Medicine | 2016-07-01 |
| FMT for MDRO Colonization in Solid Organ Transplant (NCT02816437) | University of Miami | 2016-07-01 |
| A Trial Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Ethinylestradiol and Levonorgestrel in an Oral Contraceptive Combination Drug in Healthy Postmenopausal Females (NCT02845219) | Novo Nordisk A/S | 2016-07-01 |
| Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine (NCT02722512) | Ann & Robert H Lurie Children's Hospital of Chicago | 2016-07-01 |
| Study of Lenzilumab in Previously Treated Patients With Chronic Myelomonocytic Leukemia (CMML) (NCT02546284) | Humanigen, Inc. | 2016-07-01 |
| GLS-5700 in Dengue Virus-Naïve Adults (NCT02809443) | GeneOne Life Science, Inc. | 2016-07-01 |
| A Study of Chimeric Antigen Receptor T Cells Combined With Interventional Therapy in Advanced Liver Malignancy (NCT02959151) | Shanghai GeneChem Co., Ltd. | 2016-07-01 |
| Combination of Cryosurgey and NK Immunotherapy for Recurrent Laryngeal Cancer (NCT02849314) | Fuda Cancer Hospital, Guangzhou | 2016-07-01 |
| Combination of Cryosurgery and NK Immunotherapy for Tumors in Transplanted Liver (NCT02849015) | Fuda Cancer Hospital, Guangzhou | 2016-07-01 |
| Testosterone Replacement in Renal Failure (NCT02712944) | Texas Tech University Health Sciences Center | 2016-07-01 |
| Combination of Cryosurgey and NK Immunotherapy for Recurrent Tongue Cancer (NCT02849379) | Fuda Cancer Hospital, Guangzhou | 2016-07-01 |
| A Phase 1/2 Trial of SRA737 in Subjects With Advanced Cancer (NCT02797964) | Sierra Oncology LLC - a GSK company | 2016-07-01 |
| CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor (NCT02839954) | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 2016-07-01 |
| EpCAM CAR-T for Treatment of Advanced Solid Tumors (NCT02915445) | Sichuan University | 2016-07-01 |
| XmAb5871 Bioavailability Study (NCT02867098) | Xencor, Inc. | 2016-07-01 |
| Transcranial Direct Current Stimulation (tDCS) and Task-Specific Practice for Post-stroke Neglect (NCT02892097) | Medical University of South Carolina | 2016-07-01 |
| A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa (RDEB) (NCT02810951) | Castle Creek Biosciences, LLC. | 2016-07-01 |
| Effects of Vitamin D Fortification on Vitamin D Metabolite Profiles and Status in Vitamin D Insufficient Individuals (NCT02422784) | University of Manitoba | 2016-07-01 |
| Apatinib and Irinotecan in Treating Patients With Recurrent High-grade Glioma (NCT02848794) | The First People's Hospital of Lianyungang | 2016-07-01 |
| Ursodeoxycholic Acid for Rhegmatogenous Retinal Detachment (NCT02841306) | Francine Behar-Cohen | 2016-07-01 |
| The Effect of Electronic Cigarette (ECIG) Liquid Vehicles on ECIG Acute Effects (NCT02500615) | Virginia Commonwealth University | 2016-07-01 |
| Assessing Deformable Image Registration in the Lung Using Hyperpolarized-gas MRI (NCT02995590) | University of Virginia | 2016-07-01 |
| Rebastinib Plus Antitubulin Therapy With Paclitaxel or Eribulin in Metastatic Breast Cancer (NCT02824575) | Montefiore Medical Center | 2016-07-01 |
| Using Platelet Rich Plasma in Reducing Alveolar Bone Resorption During Rapid Maxillary Expansion (NCT03028038) | Damascus University | 2016-07-01 |
| A Study to Assess the PK of AL-794 Formulations in Healthy Subjects (NCT02877160) | Alios Biopharma Inc. | 2016-06-30 |
| A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of TAK-828 Escalating Multiple-Doses in Healthy Participants (NCT02817516) | Takeda | 2016-06-30 |
| Dietary Fish Oil Intervention in Polycystic Ovary Syndrome (PCOS) (NCT04116203) | University of Alberta | 2016-06-30 |
| Repeat-Dose Pharmacokinetics Study of NRL-1 in Epilepsy Subjects (NCT02724423) | Neurelis, Inc. | 2016-06-30 |
| A Study of RO7105705 in Healthy Participants and Participants With Mild-to-Moderate Alzheimer's Disease (NCT02820896) | Genentech, Inc. | 2016-06-29 |
| A Study To Evaluate The Effect Of PF-04447943 On Qtc Interval In Healthy Adult Subjects (NCT02785770) | Pfizer | 2016-06-29 |
| Zanubrutinib (BGB-3111) in Combination With Tislelizumab (BGB-A317) in Participants With B-cell Malignancies (NCT02795182) | BeiGene | 2016-06-29 |
| Pharmacokinetic Study of Gepotidacin in Subjects With Varying Degrees of Renal Impairment and in Subjects With Normal Renal Function (NCT02729038) | GlaxoSmithKline | 2016-06-29 |
| A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid Tumors (NCT02791334) | Eli Lilly and Company | 2016-06-29 |
| Osimertinib and Bevacizumab as Treatment for EGFR-mutant Lung Cancers (NCT02803203) | Memorial Sloan Kettering Cancer Center | 2016-06-29 |
| Study of Safety and Efficacy of Ribociclib and Trametinib in Patients With Metastatic or Advanced Solid Tumors (NCT02703571) | Novartis Pharmaceuticals | 2016-06-29 |
| Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies (NCT02807844) | Novartis Pharmaceuticals | 2016-06-29 |
| Drug-Drug Interaction Study of Entinostat and Exemestane in Postmenopausal Women With ER+ Breast Cancer (NCT02820961) | Syndax Pharmaceuticals | 2016-06-29 |
| Evaluation of Microglial Activation in ALS With [18F]PBR06 (Peripheral Benzodiazepine Receptor-06) PET (NCT03876002) | Molecular NeuroImaging | 2016-06-28 |
| Perioperative FOLFIRINOX for Patients With Resectable Pancreatic Adenocarcinoma: A Pilot Study (NCT02782182) | University of Chicago | 2016-06-28 |
| Safety, Tolerability and Pharmacokinetics of 14-day Multiple Dose Titrations of TS-134 in Healthy Volunteers (NCT03742791) | Taisho Pharmaceutical R&D Inc. | 2016-06-28 |
| Trial of Panobinostat in Children With Diffuse Intrinsic Pontine Glioma (NCT02717455) | Pediatric Brain Tumor Consortium | 2016-06-28 |
| A Study to Evaluate The Effects of RO5545965 in Participants With Negative Symptoms of Schizophrenia Treated With Antipsychotics (NCT02824055) | Hoffmann-La Roche | 2016-06-27 |
| Azacitidine in Haploidentical Donor Hematopoietic Cell Transplantation (NCT02750254) | Washington University School of Medicine | 2016-06-27 |
| Plasmodium Immunotherapy for Lung Cancer (NCT02786589) | State Key Laboratory of Respiratory Disease | 2016-06-27 |
| Safety and Anti-leukemic Activity of Vodobatinib (K0706) for Treatment of Ph+ CML Resistant/Intolerant to ≥3 Prior CML Therapies (NCT02629692) | Sun Pharma Advanced Research Company Limited | 2016-06-27 |
| Vevorisertib (ARQ 751) as a Single Agent or in Combination With Other Anti-Cancer Agents, in Solid Tumors With PIK3CA / AKT / PTEN Mutations (MK-4440-001) (NCT02761694) | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 2016-06-26 |
| Pembrolizumab and Palliative Radiotherapy in Lung (NCT02587455) | Royal Marsden NHS Foundation Trust | 2016-06-24 |
| Study of Compound Danshen Dripping Pills to Treat Acute Mountain Sickness (NCT03270787) | Tasly Pharmaceuticals, Inc. | 2016-06-24 |
| A Study of ALN-HBV in Healthy Adult Volunteers and Non-cirrhotic Patients With Chronic Hepatitis B Virus (HBV) Infection (NCT02826018) | Alnylam Pharmaceuticals | 2016-06-24 |
| Pembrolizumab, Combination Chemotherapy, and Radiation Therapy Before Surgery in Treating Adult Patients With Locally Advanced Gastroesophageal Junction or Gastric Cardia Cancer That Can Be Removed by Surgery (NCT02730546) | Mayo Clinic | 2016-06-24 |
| Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer (NCT02735239) | Ludwig Institute for Cancer Research | 2016-06-24 |
| Dose Escalation and Expansion Study of GSK3359609 in Participants With Selected Advanced Solid Tumors (INDUCE-1) (NCT02723955) | GlaxoSmithKline | 2016-06-23 |
| Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary Embolism (NCT02923115) | Daiichi Sankyo | 2016-06-23 |
| 3BNC117 and 10-1074 in HIV Uninfected Adults (NCT02824536) | Rockefeller University | 2016-06-23 |
| A Dose-Finding Study of Pertuzumab (Perjeta) in Combination With Trastuzumab (Herceptin) in Healthy Male Participants and Women With Early Breast Cancer (EBC) (NCT02738970) | Hoffmann-La Roche | 2016-06-23 |
| Intravenous BI 836826 in Combination With Ibrutinib in Relapsed/Refractory CLL Patients Who Have Been Pre-treated With at Least One Prior Line of Systemic Therapy, and Who Are Eligible for Treatment With Ibrutinib (NCT02759016) | Boehringer Ingelheim | 2016-06-23 |
| Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant (NCT02797470) | AIDS Malignancy Consortium | 2016-06-23 |
| SRS and Nivolumab in Treating Patients With Newly Diagnosed Melanoma Metastases in the Brain or Spine (NCT02716948) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-06-23 |
| Pharmacokinetics and Pharmacodynamics Study of RPC1063 in RMS (NCT02797015) | Celgene | 2016-06-23 |
| Study to Evaluate Safety, Tolerability, and Immunogenicity of Candidate Human Cytomegalovirus Vaccine in Healthy Adults (NCT02826798) | VBI Vaccines Inc. | 2016-06-23 |
| Gene-Modified HIV-Protected Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma (NCT02378922) | Fred Hutchinson Cancer Center | 2016-06-22 |
| Dose-Ranging Trial of Safety & Immunogenicity of an Oral Adenoviral-Vector Based RSV Vaccine (VXA-RSV-f) (NCT02830932) | Vaxart | 2016-06-22 |
| Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of Investigational Treatments in Combination With Standard of Care Immune Checkpoint Inhibitors in Participants With Advanced Melanoma (NCT02723006) | Millennium Pharmaceuticals, Inc. | 2016-06-22 |
| Atrovent in Exercise Induced Laryngeal Obstruction (EILO) (NCT02755714) | Haukeland University Hospital | 2016-06-22 |
| Lenalidomide Combined With Vorinostat/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma of the ABC Subtype (NCT02589145) | M.D. Anderson Cancer Center | 2016-06-22 |
| Study to Evaluate the Pharmacokinetics of Single and Multiple Doses of Apremilast in Healthy Adult Male Korean Subjects (NCT02802735) | Amgen | 2016-06-22 |
| Enzalutamide and Metformin Hydrochloride in Treating Patients With Hormone-Resistant Prostate Cancer (NCT02339168) | University of California, Davis | 2016-06-22 |
| Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of AZD8871 in Healthy Subjects (NCT02814656) | AstraZeneca | 2016-06-22 |
| Dose Evaluation of MK-1966 in Combination With SD-101 in Participants With Advanced Malignancies (MK-1966-001) (NCT02731742) | Merck Sharp & Dohme LLC | 2016-06-22 |
| Dose Escalation of Lobaplatin Concurrent With IMRT for the Treatment of NPC: A Phase I Clinical Trial (NCT03188497) | Fifth Affiliated Hospital, Sun Yat-Sen University | 2016-06-22 |
| Ceritinib and Everolimus in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIB-IV Non-small Cell Lung Cancer (NCT02321501) | M.D. Anderson Cancer Center | 2016-06-22 |
| A Single Dose PD & PK Study With Two Formulations of Abediterol in Patients With Asthma (NCT02777827) | AstraZeneca | 2016-06-21 |
| Safety and Immune Response to a Clade C DNA HIV Vaccine (NCT02997969) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-06-21 |
| An Investigational Immuno-therapy Study of Experimental Medication BMS-986179 Given Alone and in Combination With Nivolumab (NCT02754141) | Bristol-Myers Squibb | 2016-06-21 |
| Evaluation of Stem Cell Therapy Effects on the Immune Response in Rheumatoid Arthritis Patients (NCT03333681) | Mashhad University of Medical Sciences | 2016-06-20 |
| A Study of INCAGN01876 in Participants With Advanced or Metastatic Solid Tumors (NCT02697591) | Incyte Biosciences International Sàrl | 2016-06-20 |
| Study to Evaluate the Effects of a High-Fat Meal on Bexagliflozin in Healthy Subjects (NCT02820298) | Theracos | 2016-06-20 |
| Study to Evaluate D2 Receptor Occupancy Following Single Intravenous Administration of ATI-9242 (NCT02824666) | Braeburn Pharmaceuticals | 2016-06-20 |